retatrutide clinical trials sign up Dosing Schedule: Proven 2026 Guide New Phase 3 retatrutide data

Retatrutide Side Effects: Phase 3 Trial Data Retatrutide side effects from 2 Phase 3 trials (1,200+ patients): nausea 26-43%, dysesthesia 4-21%, heart rate +6.7 bpm

These products are labeled "for research use only" and are not intended for human use

And the safety profile and discontinuation rates are consistent with other established members of the broadening class of GLP-1 medicines, which is reassuring, says Drucker, who has previously consulted for Eli Lilly but was also not involved in the trial

Your doctor (not you directly) can call Lilly at 1-800-545-5979 (1-800-Lilly-Rx)

For perspective, weight loss surgery typically produces 25 to 30% loss